Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list

Taking stock of the drug industry, from the lab to the medicine chest

October 8, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Illustration: STAT; Source: Eli Lilly/AP STAT+ | Compounding group sues FDA for removing Lilly's obesity drug from its shortages list The lawsuit follows an FDA announcement that Eli Lilly determined its manufacturing capacity can meet "present and projected" national demand. By Ed Silverman STAT+ | U.S. Supreme Court asks solicitor general for views on controversial Oklahoma law for regulating PBMs Last year, a U.S. appeals court struck down key parts of the Oklahoma law, ruling it was preempted by federal law. By Ed Silverman STAT+ | Harris seeks to tie expanded Medicare drug price negotiation to home care, vision, hearing coverage expansion Savings from more aggressive drug price negotiations would be used to fund a home care benefit in Medicare. By Rachel Cohrs Zhang and John Wilkerson Courtesy City Therapeutics STAT+ | Biotech veteran John Maraganore raises $135 million for his 'next-generation RNAi' startup The former CEO of Alnylam Therapeutics is launching City Therapeutics, based in Cambridge, Mass. It hopes to begin clinical trials next year. By Allison DeAngelis STAT+ | Biogen turns to telehealth company to boost its postpartum depression drug The Biogen-Talkiatry partnership resembles efforts by pharma companies like Eli Lilly and Pfizer to team up with telehealth companies. By Mario Aguilar STAT+ | ViiV takes steps to widen access to HIV prevention drug, but continues to encounter criticism ViiV continues to lock out many low and middle-income countries with its licensing deal, complained UNAIDS Executive Director Winnie Byanyima By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser